ACRS Q1 2021 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q1 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M+26.3% YoY

Gross Profit

$575,00032.4% margin

Operating Income

-$29M-1605.5% margin

Net Income

-$29M-1618.1% margin

EPS (Diluted)

$-0.57

QoQ Revenue Growth

+12.5%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$161M

Total Liabilities

$49M

Stockholders' Equity

$112M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+26.3%
Gross Profit	$575,000	$138,000	+316.7%
Operating Income	-$29M	-$16M	-84.0%
Net Income	-$29M	-$16M	-84.5%

Revenue Segments

Laboratory Research Revenue

$2M86%

Other Revenue

$242,00014%